News and Updates

Updated 1/28/2021. Check this page frequently for the latest information regarding the Prescription Drug Plan formulary, changes to coverage policies, and other relevant news for plan members.

Drug Recalls

The University of Michigan's Prescription Drug Plan will keep members up-to-date with important information regarding drug recalls. Members potentially impacted by a drug recall related to a medication's safety or efficacy may receive a letter from Magellan Rx with information about the recall, and what they should do for next steps. For more information on recent drug recalls, visit Magellan Rx's website or visit the FDA’s website.

Pharmacy Benefits and Advisory Committee (PBAC) Updates

The Pharmacy Benefits and Advisory Committee (PBAC), consisting of clinical subject matter experts within Michigan Medicine and the University of Michigan, meets regularly to review and approve changes to the Prescription Drug Plan formulary. Check the formulary for up to date formulary status. Formulary status is subject to change. Here are the latest updates.

February 2021

New Drug Products Added to Formulary

Effective February 1, 2021, the following changes will be made to the Prescription Drug Plan’s formulary. These changes will be reflected in the plan’s next bi-monthly print formulary. Review the formulary.

  • Berotralstat (Orladeyo) – Tier 3, LDD, PA, QL
  • Relugolix (Orgovyx) – Tier 2, Specialty, PA, QL
  • Lonafarnib (Zokinvy) – Tier 2, LDD, PA, QL
  • Clascoterone (Winlevi) – Tier 3, PA, QL
  • Setmelanotide (Imcivree) – Tier 2, LDD, PA, QL
  • Tramadol Solution (Qdolo) – Tier 3, PA, QL

New Generics Added to Formulary

  • Icosapent Ethyl (Generic for Vascepa)
  • Rufinamide Suspension (Generic for Banzel)
  • Timolol (Generic for Timoptic 0.5% Ocudose)
  • Nyvepria (Pegfilgrastim-apgf, biosimilar to Neulasta)
  • Tolvaptan (Generic for Samsca)
  • Asenapine (Generic for Saphris)

December 2020

Possible Mail Order Deliver Delays

The United States Postal Service (USPS) is experiencing another slowdown in the processing of mail through the USPS system. This is due to both a holiday package surge and COVID-19 staffing issues. A similar issue was noted in April 2020 shortly after the COVID-19 pandemic initially began.  For mail order prescriptions, please allow extra time to receive your order. Currently, NoviXus Pharmacy uses USPS for non-overnight deliveries only.  For refrigerated and other overnight packages they use UPS and there are no concerns at this time. 

November 2020

New Drug Products Added to Formulary

Effective November 1, 2020, the following changes will be made to the Prescription Drug Plan’s formulary. These changes will be reflected in the plan’s next bi-monthly print formulary. Review the formulary.

  • Satralizumab (Enspryng) – Tier 2, Specialty, PA, QL
  • Pralsetinib (Gavreto) – Tier 2, Specialty, PA, QL
  • Nifurtimox (Lampit) – Tier 3, PA

New Generics Added to Formulary

  • Dimethyl Fumerate (Generic for Tecfidera)
  • Lapatinib (Generic for Tykerb)
  • Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate (Generic for Atripla)
  • Fosfomycin (Generic for Monurol)
  • Tolvaptan 15 mg (Generic for Samsca)